{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T04:11:45Z","timestamp":1788754305311,"version":"build-2803163510"},"reference-count":158,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001774","name":"University of Sydney","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001774","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.semarthrit.2026.153053","type":"journal-article","created":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T15:05:11Z","timestamp":1786201511000},"page":"153053","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Research definitions of flare in non-systemic juvenile idiopathic arthritis: An OMERACT scoping review"],"prefix":"10.1016","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8810-9734","authenticated-orcid":false,"given":"Mariya Farah","family":"Kitson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praisoody","family":"Sinnappurajar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Horgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deb","family":"Constien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"O\u2019Neill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Balay-Dustrude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Magni-Manzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Munro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davinder","family":"Singh-Grewal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyn","family":"March","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.semarthrit.2026.153053_bib0001","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.3899\/jrheum.190934","article-title":"Identifying research priorities among patients and families of children with rheumatic diseases living in the United States","volume":"47","author":"Correll","year":"2020","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2026.153053_bib0002","first-page":"i100","article-title":"P173 using art workshops to facilitate research priority settings: identifying research questions with primary school children with juvenile idiopathic arthritis","volume":"61","author":"PM","year":"2022","journal-title":"Rheumatology"},{"issue":"9","key":"10.1016\/j.semarthrit.2026.153053_bib0003","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1002\/art.38741","article-title":"Efficacy and safety of adalimumab as the first and second biologic agent in juvenile idiopathic arthritis: the German Biologics JIA Registry","volume":"66","author":"Schmeling","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.153053_bib0004","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1136\/annrheumdis-2018-213902","article-title":"Treat to target (drug-free) inactive disease in DMARD-naive juvenile idiopathic arthritis: 24-month clinical outcomes of a three-armed randomised trial","volume":"78","author":"Hissink Muller","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.semarthrit.2026.153053_bib0005","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.3899\/jrheum.090369","article-title":"Developing a standardized definition for disease \"flare\" in rheumatoid arthritis (OMERACT 9 Special Interest Group)","volume":"36","author":"Bingham","year":"2009","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.153053_bib0006","first-page":"390","article-title":"International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J Rheumatol"},{"issue":"8","key":"10.1016\/j.semarthrit.2026.153053_bib0007","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.3899\/jrheum.181088","article-title":"Establishing an updated core domain set for studies in juvenile idiopathic arthritis: a report from the OMERACT 2018 JIA workshop","volume":"46","author":"Morgan","year":"2019","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.semarthrit.2026.153053_bib0008","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.153053_bib0009","first-page":"7","article-title":"[Rheumatoid arthritis in children and related forms. Updating of nomenclature, nosography, clinical manifestations and therapy, with reference to the EULAR\/WHO workshop on the care of rheumatic children, Oslo, March 1977]","volume":"29","author":"Fantini","year":"1977","journal-title":"Reumatismo"},{"issue":"6","key":"10.1016\/j.semarthrit.2026.153053_bib0010","first-page":"1","article-title":"The development of classification criteria for children with juvenile rheumatoid arthritis","volume":"38","author":"Cassidy","year":"1989","journal-title":"Bull Rheum Dis"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.153053_bib0011","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1056\/NEJMra2402073","article-title":"Juvenile idiopathic arthritis","volume":"393","author":"Sandborg","year":"2025","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.153053_bib0012","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12969-022-00770-y","article-title":"Intraarticular steroids as DMARD-sparing agents for juvenile idiopathic arthritis flares: analysis of the childhood arthritis and rheumatology research alliance registry","volume":"20","author":"Hahn","year":"2022","journal-title":"Pediatr Rheumatol Online J"},{"issue":"8","key":"10.1016\/j.semarthrit.2026.153053_bib0013","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.3899\/jrheum.200437","article-title":"Biologic switching among nonsystemic juvenile idiopathic arthritis patients: a cohort study in the childhood arthritis and rheumatology research alliance registry","volume":"48","author":"Mannion","year":"2021","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2026.153053_bib0014","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/acr.24994","article-title":"Disease recapture rates after medication discontinuation and flare in juvenile idiopathic arthritis: an observational study within the childhood arthritis and rheumatology research alliance registry","volume":"75","author":"Ringold","year":"2023","journal-title":"Arthritis Care Res"},{"issue":"101154438","key":"10.1016\/j.semarthrit.2026.153053_bib0015","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s13075-015-0723-1","article-title":"MRP8\/14 serum levels as a predictor of response to starting and stopping anti-TNF treatment in juvenile idiopathic arthritis","volume":"17","author":"Anink","year":"2015","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.153053_bib0016","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1136\/ard.2010.135731","article-title":"Tumour necrosis factor (TNF)-blocking agents in juvenile psoriatic arthritis: are they effective?","volume":"70","author":"Otten","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.semarthrit.2026.153053_bib0017","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.3899\/jrheum.110145","article-title":"Tumor necrosis factor-blocking agents for children with enthesitis-related arthritis\u2013data from the Dutch arthritis and biologicals in children register, 1999-2010","volume":"38","author":"Otten","year":"2011","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.153053_bib0018","first-page":"12","article-title":"Predictive factors of relapse after methotrexate discontinuation in juvenile idiopathic arthritis patients with inactive disease","volume":"1","author":"Azevedo","year":"2022","journal-title":"ARP Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.153053_bib0019","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13075-021-02492-0","article-title":"Re-treatment with etanercept is as effective as the initial firstline treatment in patients with juvenile idiopathic arthritis","volume":"23","author":"Klotsche","year":"2021","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"10.1016\/j.semarthrit.2026.153053_bib0020","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1136\/annrheumdis-2017-211968","article-title":"Time spent in inactive disease before MTX withdrawal is relevant with regard to the flare risk in patients with JIA","volume":"77","author":"Klotsche","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.semarthrit.2026.153053_bib0021","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/acr.20205","article-title":"Performance of rheumatoid arthritis disease activity measures and juvenile arthritis disease activity scores in polyarticular-course juvenile idiopathic arthritis: analysis of their ability to classify the American College of Rheumatology pediatric measur","volume":"62","author":"Ringold","year":"2010","journal-title":"Arthritis Care Res"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.153053_bib0022","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s41687-021-00328-8","article-title":"The value of the patient global health assessment in polyarticular juvenile idiopathic arthritis: a nested cohort study","volume":"5","author":"Trachtman","year":"2021","journal-title":"J Patient-Rep Outcomes"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.153053_bib0023","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/acr.24763","article-title":"Development and validation of a juvenile spondyloarthritis disease flare measure: ascertaining flare in patients with inactive disease","volume":"75","author":"Weiss","year":"2023","journal-title":"Arthritis Care Res"},{"issue":"7","key":"10.1016\/j.semarthrit.2026.153053_bib0024","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1136\/annrheumdis-2021-222029","article-title":"Prevention of disease flares by risk-adapted stratification of therapy withdrawal in juvenile idiopathic arthritis: results from the PREVENT-JIA trial","volume":"81","author":"Gerss","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"23","key":"10.1016\/j.semarthrit.2026.153053_bib0025","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1001\/jama.2013.6768","article-title":"Effects of the live attenuated measles-mumps-rubella booster vaccination on disease activity in patients with juvenile idiopathic arthritis: a randomized trial","volume":"309","author":"Heijstek","year":"2013","journal-title":"JAMA"},{"issue":"39","key":"10.1016\/j.semarthrit.2026.153053_bib0026","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3310\/hta9390","article-title":"Is hydrotherapy cost-effective? A randomised controlled trial of combined hydrotherapy programmes compared with physiotherapy land techniques in children with juvenile idiopathic arthritis","volume":"9","author":"Epps","year":"2005","journal-title":"Health Technol Assess"},{"issue":"6","key":"10.1016\/j.semarthrit.2026.153053_bib0027","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1136\/annrheumdis-2014-207164","article-title":"The risk and nature of flares in juvenile idiopathic arthritis: results from the ReACCh-out cohort","volume":"75","author":"Guzman","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2026.153053_bib0028","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.665170","article-title":"Tapering of biological agents in juvenile ERA patients in daily clinical practice","volume":"8","author":"Liao","year":"2021","journal-title":"Front Med"},{"issue":"10","key":"10.1016\/j.semarthrit.2026.153053_bib0029","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.3899\/jrheum.2022-1305","article-title":"What to expect when systemic treatment in juvenile idiopathic arthritis is withdrawn?","volume":"50","author":"Nieto-Gonzalez","year":"2023","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.semarthrit.2026.153053_bib0030","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/acr.23435","article-title":"Flares after withdrawal of biologic therapies in juvenile idiopathic arthritis: clinical and laboratory correlates of remission duration","volume":"70","author":"Simonini","year":"2018","journal-title":"Arthritis Care Res"},{"issue":"3","key":"10.1016\/j.semarthrit.2026.153053_bib0031","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/14712598.2023.2185132","article-title":"Withdrawal of biologic therapy in juvenile idiopathic arthritis due to remission: predictors of flare and outcomes","volume":"23","author":"Tanatar","year":"2023","journal-title":"Expert Opin Biol Ther"},{"issue":"10","key":"10.1016\/j.semarthrit.2026.153053_bib0032","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1007\/s10067-022-06275-z","article-title":"Sacroiliitis at diagnosis as a protective predictor against disease flare after stopping medication: outcomes of a Southeast Asian enthesitis-related arthritis (ERA) longitudinal cohort","volume":"41","author":"Teh","year":"2022","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2026.153053_bib0033","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1007\/s10067-024-06928-1","article-title":"Anti-tumor necrosis factor (aTNF) weaning strategy in juvenile idiopathic arthritis (JIA): does duration matter?","volume":"43","author":"Teh","year":"2024","journal-title":"Clin Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2026.153053_bib0034","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1007\/s10067-020-05520-7","article-title":"Outcomes and predictors of juvenile idiopathic arthritis in Southeast Asia: a Singapore longitudinal study over a decade","volume":"40","author":"Teh","year":"2021","journal-title":"Clin Rheumatol"},{"issue":"8","key":"10.1016\/j.semarthrit.2026.153053_bib0035","article-title":"Real life treatment in juvenile idiopathic arthritis: is remission long lasting?","volume":"21","author":"Trives-Folguera","year":"2025","journal-title":"Reum Clin"},{"issue":"101519204","key":"10.1016\/j.semarthrit.2026.153053_bib0036","article-title":"Vaccinations do not increase arthritis flares in juvenile idiopathic arthritis: a study of the relationship between routine childhood vaccinations on the Australian immunisation schedule and arthritis activity in children with juvenile idiopathic arthriti","volume":"2020","author":"Alfayadh","year":"2020","journal-title":"Int J Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.153053_bib0037","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10067-008-0995-9","article-title":"Anakinra in the treatment of polyarticular-course juvenile rheumatoid arthritis: safety and preliminary efficacy results of a randomized multicenter study","volume":"28","author":"Ilowite","year":"2009","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.153053_bib0038","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12969-021-00653-8","article-title":"Infection with SARS-CoV-2 causes flares in patients with juvenile idiopathic arthritis in remission or inactive disease on medication","volume":"19","author":"Hugle","year":"2021","journal-title":"Pediatr Rheumatol Online J"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.153053_bib0039","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12969-022-00666-x","article-title":"The efficacy and safety of intra-articular injection of triamcinolone acetonide versus triamcinolone hexacetonide for treatment of juvenile idiopathic arthritis","volume":"20","author":"Rubin","year":"2022","journal-title":"Pediatr Rheumatol Online J."},{"issue":"8","key":"10.1016\/j.semarthrit.2026.153053_bib0040","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/RHU.0000000000002032","article-title":"Can whole-body magnetic resonance imaging predict relapse in juvenile idiopathic arthritis? A longitudinal pilot study","volume":"29","author":"Bhalla","year":"2023","journal-title":"J Clin Rheumatol"},{"issue":"10","key":"10.1016\/j.semarthrit.2026.153053_bib0041","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.1093\/rheumatology\/keaf321","article-title":"Disease modifying anti-rheumatic drug treatment cycles and rates of flare in juvenile idiopathic arthritis-a tale of sisyphean endeavour?","volume":"64","author":"Bugeja","year":"2025","journal-title":"Rheumatology"},{"issue":"12","key":"10.1016\/j.semarthrit.2026.153053_bib0042","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1136\/annrheumdis-2019-216059","article-title":"Immunome perturbation is present in patients with juvenile idiopathic arthritis who are in remission and will relapse upon anti-tnf\u03b1 withdrawal","volume":"78","author":"Leong","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.semarthrit.2026.153053_bib0043","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1542\/peds.100.6.994","article-title":"Discontinuation of methotrexate treatment in juvenile rheumatoid arthritis","volume":"100","author":"Gottlieb","year":"1997","journal-title":"Pediatrics"},{"key":"10.1016\/j.semarthrit.2026.153053_bib0044","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s41927-022-00249-z","article-title":"Comparison of efficacy between triamcinolone acetonide and triamcinolone hexacetonide for intraarticular therapy in juvenile idiopathic arthritis: a retrospective analysis","volume":"6","author":"Chun","year":"2022","journal-title":"BMC Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.153053_bib0045","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1136\/ard.2003.005686","article-title":"Methotrexate treatment in juvenile idiopathic arthritis: when is the right time to stop?","volume":"63","author":"Foell","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.153053_bib0046","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12969-025-01171-7","article-title":"Predictors of relapse after withdrawing biotherapies in children with inactive juvenile idiopathic arthritis: a retrospective cohort study of the JIR cohort","volume":"23","author":"Jallot","year":"2025","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.semarthrit.2026.153053_bib0047","article-title":"Uveitis as predictor of disease flare after the first anti-TNF withdrawal in oligoarticular and polyarticular juvenile idiopathic arthritis: a multicentric Italian experience","author":"Maccora","year":"2024","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"10.1016\/j.semarthrit.2026.153053_bib0048","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.3899\/jrheum.091241","article-title":"Cross-sectional and longitudinal evaluation of bone mass in children and young adults with juvenile idiopathic arthritis: the role of bone mass determinants in a large cohort of patients","volume":"37","author":"Stagi","year":"2010","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.153053_bib0049","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/art.22399","article-title":"Safety and efficacy of meningococcal c vaccination in juvenile idiopathic arthritis","volume":"56","author":"Zonneveld-Huijssoon","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.semarthrit.2026.153053_bib0050","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.1093\/rheumatology\/keac178","article-title":"Soluble interleukin-2 receptor serum levels facilitate prediction of relapses in subgroups of patients with juvenile idiopathic arthritis","volume":"61","author":"Ziegler","year":"2022","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.semarthrit.2026.153053_bib0051","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/mr\/road053","article-title":"Subclinical enthesitis in enthesitis-related arthritis and sacroiliitis associated with familial Mediterranean fever","volume":"34","author":"Sener","year":"2024","journal-title":"Mod Rheumatol"},{"issue":"9","key":"10.1016\/j.semarthrit.2026.153053_bib0052","first-page":"1868","article-title":"Is there a role for arthroscopic synovectomy in oligoarticular juvenile idiopathic arthritis?","volume":"33","author":"Toledo","year":"2006","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.153053_bib0053","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12969-020-0398-2","article-title":"The use of S100 proteins testing in juvenile idiopathic arthritis and autoinflammatory diseases in a pediatric clinical setting: a retrospective analysis","volume":"18","author":"Aljaberi","year":"2020","journal-title":"Pediatr Rheumatol Online J"},{"issue":"3","key":"10.1016\/j.semarthrit.2026.153053_bib0054","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/acr.24483","article-title":"Temporal relationship between juvenile idiopathic arthritis disease activity and uveitis disease activity","volume":"74","author":"Liebling","year":"2022","journal-title":"Arthritis Care Res"},{"issue":"3","key":"10.1016\/j.semarthrit.2026.153053_bib0055","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/RHU.0000000000001170","article-title":"Procalcitonin differs in children with infection and children with disease flares in juvenile idiopathic arthritis","volume":"27","author":"Trachtman","year":"2021","journal-title":"J Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2026.153053_bib0056","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/acr.22477","article-title":"Impact of medication withdrawal method on flare-free survival in patients with juvenile idiopathic arthritis on combination therapy","volume":"67","author":"Chang","year":"2015","journal-title":"Arthritis Care Res"},{"issue":"8","key":"10.1016\/j.semarthrit.2026.153053_bib0057","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1136\/ard.58.8.475","article-title":"Pregnancy and early onset pauciarticular juvenile chronic arthritis","volume":"58","author":"Musiej-Nowakowska","year":"1999","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.semarthrit.2026.153053_bib0058","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1136\/annrheumdis-2017-211696","article-title":"Baseline ultrasound examination as possible predictor of relapse in patients affected by juvenile idiopathic arthritis (JIA)","volume":"77","author":"De Lucia","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.semarthrit.2026.153053_bib0059","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1093\/rheumatology\/kez590","article-title":"MRP8\/14 and neutrophil elastase for predicting treatment response and occurrence of flare in patients with juvenile idiopathic arthritis","volume":"59","author":"Barendregt","year":"2020","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.semarthrit.2026.153053_bib0060","first-page":"424","article-title":"Long-term outcome of anti-tumor necrosis factor alpha blockade in the treatment of juvenile spondyloarthritis","volume":"32","author":"Hugle","year":"2014","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.153053_bib0061","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1136\/annrheumdis-2011-201264","article-title":"Ultrasound-detected synovial abnormalities are frequent in clinically inactive juvenile idiopathic arthritis, but do not predict a flare of synovitis","volume":"72","author":"Magni-Manzoni","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.semarthrit.2026.153053_bib0062","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1007\/s10067-023-06569-w","article-title":"Outcomes of intraarticular triamcinolone acetonide injection in children with non-systemic juvenile idiopathic arthritis","volume":"42","author":"Sukharomana","year":"2023","journal-title":"Clin Rheumatol"},{"issue":"9","key":"10.1016\/j.semarthrit.2026.153053_bib0063","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1093\/rheumatology\/ker165","article-title":"Outcome and predicting factors of single and multiple intra-articular corticosteroid injections in children with juvenile idiopathic arthritis","volume":"50","author":"Lanni","year":"2011","journal-title":"Rheumatology"},{"issue":"7","key":"10.1016\/j.semarthrit.2026.153053_bib0064","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s10067-011-1709-2","article-title":"Serum heat shock protein 60 can predict remission of flare-up in juvenile idiopathic arthritis","volume":"30","author":"Wu","year":"2011","journal-title":"Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2026.153053_bib0065","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3109\/14397595.2015.1109784","article-title":"Prediction of long-term remission of oligo\/polyarticular juvenile idiopathic arthritis with S100A12 and vascular endothelial growth factor","volume":"26","author":"Yamasaki","year":"2016","journal-title":"Mod Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2026.153053_bib0066","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3899\/jrheum.170681","article-title":"Flares of disease in children with clinically inactive juvenile idiopathic arthritis were not correlated with ultrasound findings","volume":"45","author":"Zhao","year":"2018","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.153053_bib0067","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12969-018-0288-z","article-title":"Juvenile idiopathic arthritis managed in the new millennium: one year outcomes of an inception cohort of Australian children","volume":"16","author":"Tiller","year":"2018","journal-title":"Pediatr Rheumatol Online J"},{"issue":"13","key":"10.1016\/j.semarthrit.2026.153053_bib0068","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1001\/jama.2010.375","article-title":"Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial","volume":"303","author":"Foell","year":"2010","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.semarthrit.2026.153053_bib0069","doi-asserted-by":"crossref","first-page":"202","DOI":"10.5114\/reum.2020.98431","article-title":"Blood calprotectin in children with juvenile idiopathic arthritis: relationship to flare development after discontinuation of treatment","volume":"58","author":"Boyko","year":"2020","journal-title":"Reumatologia"},{"issue":"9","key":"10.1016\/j.semarthrit.2026.153053_bib0070","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1007\/s00296-012-2642-7","article-title":"Clinical trial of etanercept tapering in juvenile idiopathic arthritis during remission","volume":"33","author":"Cai","year":"2013","journal-title":"Rheumatol Int"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.153053_bib0071","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.3390\/ijms24021671","article-title":"The role of serum calprotectin in defining disease outcomes in non-systemic juvenile idiopathic arthritis: a pilot study","volume":"24","author":"d\u2019Angelo","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.semarthrit.2026.153053_bib0072","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1136\/annrheumdis-2012-201329","article-title":"Phagocyte-specific S100 proteins and high-sensitivity C reactive protein as biomarkers for a risk-adapted treatment to maintain remission in juvenile idiopathic arthritis: a comparative study","volume":"71","author":"Gerss","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.semarthrit.2026.153053_bib0073","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1007\/s00431-015-2553-1","article-title":"Atopy in children with the enthesitis-related arthritis (ERA) subtype of juvenile idiopathic arthritis is associated with a worse outcome","volume":"174","author":"Guo","year":"2015","journal-title":"Eur J Pediatr"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.153053_bib0074","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3899\/jrheum.160197","article-title":"Predicting which children with juvenile idiopathic arthritis will have a severe disease course: results from the ReACCh-out cohort","volume":"44","author":"Guzman","year":"2017","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.semarthrit.2026.153053_bib0075","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s00296-018-4062-9","article-title":"Juvenile idiopathic arthritis in the biologic era: predictors of the disease progression and need for early introduction of biologic treatment","volume":"38","author":"Nalbanti","year":"2018","journal-title":"Rheumatol Int"},{"issue":"em6, 8106411","key":"10.1016\/j.semarthrit.2026.153053_bib0076","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejrad.2017.01.003","article-title":"Dynamic contrast-enhanced magnetic resonance imaging can play a role in predicting flare in juvenile idiopathic arthritis","volume":"88","author":"Nusman","year":"2017","journal-title":"Eur J Radiol"},{"issue":"10","key":"10.1016\/j.semarthrit.2026.153053_bib0077","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1080\/14712598.2022.2105140","article-title":"Comparison of the outcomes between early and late anti-tumor necrosis factor therapy in patients with enthesitis-related subcategory of juvenile idiopathic arthritis: a multi-center study in Southeast Asia","volume":"22","author":"Vilaiyuk","year":"2022","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.semarthrit.2026.153053_bib0078","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.3390\/biomedicines13102329","article-title":"Can we successfully discontinue anti-tumor necrosis factor-alpha treatment in children with non-systemic juvenile idiopathic arthritis? The experience of a tertiary center","volume":"13","author":"Alexeeva","year":"2025","journal-title":"Biomedicines"},{"issue":"7","key":"10.1016\/j.semarthrit.2026.153053_bib0079","doi-asserted-by":"crossref","first-page":"956","DOI":"10.3899\/jrheum.170794","article-title":"Predictors of flare following etanercept withdrawal in patients with rheumatoid factor-negative juvenile idiopathic arthritis who reached remission while taking medication","volume":"45","author":"Aquilani","year":"2018","journal-title":"J Rheumatol"},{"issue":"10","key":"10.1016\/j.semarthrit.2026.153053_bib0080","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1002\/art.30502","article-title":"Clinical outcomes after withdrawal of anti-tumor necrosis factor alpha therapy in patients with juvenile idiopathic arthritis: a twelve-year experience","volume":"63","author":"Baszis","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.153053_bib0081","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12969-025-01075-6","article-title":"Clinical remission rate and drug withdrawal status in articular juvenile idiopathic arthritis","volume":"23","author":"Oshima","year":"2025","journal-title":"Pediatr Rheumatol Online J"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.153053_bib0082","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12969-023-00860-5","article-title":"How common is remission in rheumatoid factor-positive juvenile idiopathic arthritis patients? The multicenter Pediatric Rheumatology Academy (PeRA) research group experience","volume":"21","author":"Ozdel","year":"2023","journal-title":"Pediatr Rheumatol Online J"},{"issue":"10","key":"10.1016\/j.semarthrit.2026.153053_bib0083","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1007\/s00296-012-2468-3","article-title":"Clinical remission in juvenile idiopathic arthritis after termination of etanercept","volume":"33","author":"Postepski","year":"2013","journal-title":"Rheumatol Int"},{"issue":"9","key":"10.1016\/j.semarthrit.2026.153053_bib0084","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1007\/s10067-017-3682-x","article-title":"Treatment response to etanercept in methotrexate refractory juvenile idiopathic arthritis: an analysis of predictors and long-term outcomes","volume":"36","author":"Su","year":"2017","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2026.153053_bib0085","article-title":"Outcomes of children with juvenile idiopathic arthritis receiving biological disease-modifying anti-rheumatic drugs: a retrospective single-centre experience from India","volume":"38","author":"Kaur","year":"2025","journal-title":"Lancet Reg Health Southeast Asia"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.153053_bib0086","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1186\/s13023-024-03330-7","article-title":"Impact of the COVID-19 pandemic on the quality of care for juvenile idiopathic arthritis patients: insights from Thailand","volume":"19","author":"Pinpattanapong","year":"2024","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.153053_bib0087","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/ard-2022-222849","article-title":"Secukinumab in enthesitis-related arthritis and juvenile psoriatic arthritis: a randomised, double-blind, placebo-controlled, treatment withdrawal, phase 3 trial","volume":"82","author":"Brunner","year":"2023","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.153053_bib0088","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/annrheumdis-2016-210456","article-title":"Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: results of a multicentre, double-blind, randomised-withdrawal trial","volume":"77","author":"Brunner","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.semarthrit.2026.153053_bib0089","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1136\/annrheumdis-2014-205351","article-title":"Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial","volume":"74","author":"Brunner","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.semarthrit.2026.153053_bib0090","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1056\/NEJM200003163421103","article-title":"Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group","volume":"342","author":"Lovell","year":"2000","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.semarthrit.2026.153053_bib0091","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa0706290","article-title":"Adalimumab with or without methotrexate in juvenile rheumatoid arthritis","volume":"359","author":"Lovell","year":"2008","journal-title":"N Engl J Med"},{"issue":"10401","key":"10.1016\/j.semarthrit.2026.153053_bib0092","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0140-6736(23)00921-2","article-title":"Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial","volume":"402","author":"Ramanan","year":"2023","journal-title":"Lancet"},{"issue":"10315","key":"10.1016\/j.semarthrit.2026.153053_bib0093","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/S0140-6736(21)01255-1","article-title":"Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial","volume":"398","author":"Ruperto","year":"2021","journal-title":"Lancet"},{"issue":"9636","key":"10.1016\/j.semarthrit.2026.153053_bib0094","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0140-6736(08)60998-8","article-title":"Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial","volume":"372","author":"Ruperto","year":"2008","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.semarthrit.2026.153053_bib0095","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1002\/art.34343","article-title":"Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis","volume":"64","author":"Wallace","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.semarthrit.2026.153053_bib0096","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1002\/art.39145","article-title":"Efficacy and safety of etanercept in patients with the enthesitis-related arthritis category of juvenile idiopathic arthritis: results from a phase III randomized, double-blind study","volume":"67","author":"Horneff","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.153053_bib0097","first-page":"150","article-title":"Minimal clinically important differences of the childhood health assessment questionnaire","volume":"32","author":"Brunner","year":"2005","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.153053_bib0098","first-page":"366","article-title":"Soluble intercellular adhesion molecule-1 and E-selectin as markers of disease activity and endothelial activation in juvenile idiopathic arthritis","volume":"32","author":"Bloom","year":"2005","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.153053_bib0099","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/rheumatology\/ket310","article-title":"Interpretation of the Juvenile Arthritis Disease Activity Score: responsiveness, clinically important differences and levels of disease activity in prospective cohorts of patients with juvenile idiopathic arthritis","volume":"53","author":"Bulatovic Calasan","year":"2014","journal-title":"Rheumatology"},{"issue":"101248897","key":"10.1016\/j.semarthrit.2026.153053_bib0100","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1546-0096-11-10","article-title":"Prospective surveillance study of acute respiratory infections, influenza-like illness and seasonal influenza vaccine in a cohort of juvenile idiopathic arthritis patients","volume":"11","author":"Carvalho","year":"2013","journal-title":"Pediatr Rheumatol Online J"},{"issue":"4","key":"10.1016\/j.semarthrit.2026.153053_bib0101","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/art.20125","article-title":"Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations","volume":"50","author":"Foell","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.semarthrit.2026.153053_bib0102","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/art.40727","article-title":"Serum S100A8\/A9 and S100A12 levels in children with polyarticular forms of juvenile idiopathic arthritis: relationship to maintenance of clinically inactive disease during anti-tumor necrosis factor therapy and occurrence of disease flare after discontinu","volume":"71","author":"Hinze","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2026.153053_bib0103","first-page":"829","article-title":"An open label study to establish dosing recommendations for nabumetone in juvenile rheumatoid arthritis","volume":"30","author":"Goodman","year":"2003","journal-title":"J Rheumatol"},{"issue":"12","key":"10.1016\/j.semarthrit.2026.153053_bib0104","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1515\/CCLM.2009.288","article-title":"Antibodies to mutated citrullinated vimentin and antibodies to cyclic citrullinated peptides in juvenile idiopathic arthritis","volume":"47","author":"Kuna","year":"2009","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.semarthrit.2026.153053_bib0105","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2021-001646","article-title":"Serum calprotectin (S100A8\/A9): a promising biomarker in diagnosis and follow-up in different subgroups of juvenile idiopathic arthritis","volume":"7","author":"La","year":"2021","journal-title":"RMD Open"},{"issue":"4","key":"10.1016\/j.semarthrit.2026.153053_bib0106","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/art.40404","article-title":"High levels of DEK autoantibodies in sera of patients with polyarticular juvenile idiopathic arthritis and with early disease flares following cessation of anti-tumor necrosis factor therapy","volume":"70","author":"Mor-Vaknin","year":"2018","journal-title":"Arthritis Rheumatol"},{"issue":"7","key":"10.1016\/j.semarthrit.2026.153053_bib0107","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/acr.20183","article-title":"Safety and immunogenicity of varicella vaccine in patients with juvenile rheumatic diseases receiving methotrexate and corticosteroids","volume":"62","author":"Pileggi","year":"2010","journal-title":"Arthritis Care Res"},{"issue":"4","key":"10.1016\/j.semarthrit.2026.153053_bib0108","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/art.10885","article-title":"Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type","volume":"48","author":"Quartier","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.semarthrit.2026.153053_bib0109","first-page":"436","article-title":"Safety and efficacy of influenza vaccination in a prospective longitudinal study of 31 children with juvenile idiopathic arthritis","volume":"30","author":"Toplak","year":"2012","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"10.1016\/j.semarthrit.2026.153053_bib0110","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1002\/art.40509","article-title":"Risk, timing, and predictors of disease flare after discontinuation of anti-tumor necrosis factor therapy in children with polyarticular forms of juvenile idiopathic arthritis with clinically inactive disease","volume":"70","author":"Lovell","year":"2018","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.153053_bib0111","first-page":"131","article-title":"The 'head-to-head' comparison of etanercept and infliximab in treating children with juvenile idiopathic arthritis","volume":"29","author":"Lamot","year":"2011","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"10.1016\/j.semarthrit.2026.153053_bib0112","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/art.1780340714","article-title":"Pregnancy in patients with a history of Juvenile rheumatoid-arthritis","volume":"34","author":"Ostensen","year":"1991","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.153053_bib0113","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s42358-025-00459-2","article-title":"A real-life study of juvenile idiopathic arthritis from two Brazilian referral centers for pediatric rheumatology","volume":"65","author":"Terrazas","year":"2025","journal-title":"Adv Rheumatol"},{"issue":"9","key":"10.1016\/j.semarthrit.2026.153053_bib0114","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.3899\/jrheum.131421","article-title":"Determinants of vitamin D levels in children, adolescents, and young adults with juvenile idiopathic arthritis","volume":"41","author":"Stagi","year":"2014","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.153053_bib0115","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13063-022-07038-6","article-title":"Biologic abatement and capturing kids' outcomes and flare frequency in juvenile spondyloarthritis (BACK-OFF JSpA): study protocol for a randomized pragmatic trial","volume":"24","author":"Weiss","year":"2023","journal-title":"Trials"},{"issue":"5","key":"10.1016\/j.semarthrit.2026.153053_bib0116","doi-asserted-by":"crossref","DOI":"10.1002\/pds.5803","article-title":"Validation of new medication use algorithms as proxies for worsening disease activity in patients with juvenile idiopathic arthritis","volume":"33","author":"Saito","year":"2024","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.semarthrit.2026.153053_bib0117","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s43166-022-00143-z","article-title":"Safety of the BNT162b2 mRNA COVID-19 vaccine in children and adolescents with juvenile idiopathic arthritis: a tertiary-center early experience","volume":"49","author":"Abdelgalil","year":"2022","journal-title":"Egypt Rheumatol Rehabil"},{"issue":"18","key":"10.1016\/j.semarthrit.2026.153053_bib0118","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1016\/j.vaccine.2023.03.074","article-title":"Safety of Measles-Mumps-Rubella booster vaccination in patients with juvenile idiopathic arthritis: a long-term follow-up study","volume":"41","author":"Hamad Saied","year":"2023","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.semarthrit.2026.153053_bib0119","doi-asserted-by":"crossref","first-page":"681","DOI":"10.24953\/turkjpediatr.2024.4889","article-title":"Role of serum procalcitonin in differentiating disease flare and systemic bacterial infection among febrile children with known chronic rheumatic diseases: a cross-sectional study","volume":"66","author":"Majumder","year":"2024","journal-title":"Turk J Pediatr"},{"key":"10.1016\/j.semarthrit.2026.153053_bib0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2025.152774","article-title":"The effectiveness and safety of rituximab in juvenile idiopathic arthritis: hints from the ITHACA monocentric registry","volume":"74","author":"Pellico","year":"2025","journal-title":"Semin Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.semarthrit.2026.153053_bib0121","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1136\/ard.2003.013201","article-title":"Hepatitis B vaccination in children with juvenile idiopathic arthritis","volume":"63","author":"Kasapcopur","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.semarthrit.2026.153053_bib0122","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.1093\/rheumatology\/keac105","article-title":"Robust neutralizing antibody response to SARS-CoV-2 mRNA vaccination in adolescents and young adults with childhood-onset rheumatic diseases","volume":"61","author":"Yeo","year":"2022","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.153053_bib0123","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/acr.24768","article-title":"Increased relapse rate during COVID-19 lockdown in an Italian cohort of children with juvenile idiopathic arthritis","volume":"75","author":"Naddei","year":"2023","journal-title":"Arthritis Care Res"},{"issue":"6","key":"10.1016\/j.semarthrit.2026.153053_bib0124","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1080\/00325481.2022.2074700","article-title":"Safety of COVID-19 vaccines and disease flares after vaccines in children with rheumatic disease","volume":"134","author":"Arslanoglu Aydin","year":"2022","journal-title":"Postgrad Med"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.153053_bib0125","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4103\/injr.injr_267_20","article-title":"Treatment adherence and disease status among children with rheumatological diseases during COVID-19 Pandemic: a cross-sectional study from a tertiary care center","volume":"16","author":"Mahadevan","year":"2021","journal-title":"Indian J Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2026.153053_bib0126","first-page":"589","article-title":"Influenza vaccination in children with chronic rheumatic diseases and long-term immunosuppressive therapy","volume":"19","author":"Kanakoudi-Tsakalidou","year":"2001","journal-title":"Clin Exp Rheumatol"},{"issue":"11","key":"10.1016\/j.semarthrit.2026.153053_bib0127","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/art.42240","article-title":"Joint-specific memory and sustained risk for new Joint accumulation in autoimmune arthritis","volume":"74","author":"Chang","year":"2022","journal-title":"Arthritis Rheumatol"},{"issue":"101627166","key":"10.1016\/j.semarthrit.2026.153053_bib0128","article-title":"A granulocyte-specific protein S100A12 as a potential prognostic factor affecting aggressiveness of therapy in patients with juvenile idiopathic arthritis","volume":"2018","author":"Orczyk","year":"2018","journal-title":"J Immunol Res"},{"issue":"9","key":"10.1016\/j.semarthrit.2026.153053_bib0129","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1016\/j.vaccine.2020.01.037","article-title":"Live attenuated MMR\/V booster vaccines in children with rheumatic diseases on immunosuppressive therapy are safe: multicenter, retrospective data collection","volume":"38","author":"Uziel","year":"2020","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.153053_bib0130","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12969-021-00594-2","article-title":"The vaccine coverage and vaccine immunity status and risk factors of non-protective levels of antibodies against vaccines in children with juvenile idiopathic arthritis: cross-sectional Russian tertiary Centre study","volume":"19","author":"Kostik","year":"2021","journal-title":"Pediatr Rheumatol Online J"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.153053_bib0131","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10067-013-2435-8","article-title":"Survey about tolerance of the AS03-adjuvanted H1N1 influenza vaccine in children with rheumatic diseases","volume":"33","author":"Sengler","year":"2014","journal-title":"Clin Rheumatol"},{"issue":"101615492","key":"10.1016\/j.semarthrit.2026.153053_bib0132","article-title":"Outcomes in children with rheumatic diseases following COVID-19 vaccination and infection: data from a large two-center cohort study in Thailand","volume":"11","author":"Lerkvaleekul","year":"2023","journal-title":"Front Pediatr"},{"issue":"7","key":"10.1016\/j.semarthrit.2026.153053_bib0133","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s00296-022-05108-1","article-title":"Evaluation of flare rate and reduction strategies for bDMARDs in juvenile idiopathic arthritis: real world data from a single-centre cohort","volume":"42","author":"Garcia-Fernandez","year":"2022","journal-title":"Rheumatol Int"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.153053_bib0134","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12969-017-0208-7","article-title":"Patients with juvenile idiopathic arthritis in clinical remission with positive power doppler signal in joint ultrasonography have an increased rate of clinical flare: a prospective study","volume":"15","author":"Miotto E Silva","year":"2017","journal-title":"Pediatr Rheumatol Online J"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.153053_bib0135","first-page":"120","article-title":"Duration of inactive disease while off disease-modifying anti-rheumatic drugs seems to influence flare rates in juvenile idiopathic arthritis: an observational retrospective study, Duration of inactive disease while off disease-modifying anti-rheumatic dr","volume":"46","author":"Aires","year":"2021","journal-title":"Acta Reumatol Port"},{"issue":"101615492","key":"10.1016\/j.semarthrit.2026.153053_bib0136","article-title":"Uveitis is a risk factor for juvenile idiopathic arthritis' Significant flare in patients treated with biologics","volume":"10","author":"Kostik","year":"2022","journal-title":"Front Pediatr"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.153053_bib0137","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/acr.24757","article-title":"Predictive value of magnetic resonance imaging in patients with juvenile idiopathic arthritis in clinical remission","volume":"75","author":"Mazzoni","year":"2023","journal-title":"Arthritis Care Res"},{"issue":"7","key":"10.1016\/j.semarthrit.2026.153053_bib0138","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/acr.21947","article-title":"Delineating the role of multiple intraarticular corticosteroid injections in the management of juvenile idiopathic arthritis in the biologic era","volume":"65","author":"Papadopoulou","year":"2013","journal-title":"Arthritis Care Res"},{"issue":"5","key":"10.1016\/j.semarthrit.2026.153053_bib0139","first-page":"625","article-title":"Efficacy of folinic acid in reducing methotrexate toxicity in juvenile idiopathic arthritis","volume":"17","author":"Ravelli","year":"1999","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"10.1016\/j.semarthrit.2026.153053_bib0140","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1007\/s10067-022-06165-4","article-title":"Use of MRP8\/14 in clinical practice as a predictor of outcome after methotrexate withdrawal in patients with juvenile idiopathic arthritis","volume":"41","author":"Sumner","year":"2022","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.153053_bib0141","doi-asserted-by":"crossref","first-page":"426","DOI":"10.55563\/clinexprheumatol\/rxidz4","article-title":"Analysis of arthritis flares after achievement of inactive disease with methotrexate monotherapy in juvenile idiopathic arthritis","volume":"39","author":"Bava","year":"2021","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2026.153053_bib0142","first-page":"421","article-title":"Responsiveness of clinical measures to flare of disease activity in juvenile idiopathic arthritis","volume":"23","author":"Magni-Manzoni","year":"2005","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2026.153053_bib0143","doi-asserted-by":"crossref","first-page":"602","DOI":"10.46497\/ArchRheumatol.2023.10035","article-title":"Risk of flare in juvenile idiopathic arthritis: is it related to the methotrexate treatment strategy or patient characteristics?","volume":"38","author":"Isguder","year":"2023","journal-title":"Arch Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.153053_bib0144","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.beha.2004.05.003","article-title":"Stem cell transplantation for autoimmune disorders. Refractory juvenile idiopathic arthritis","volume":"17","author":"Wulffraat","year":"2004","journal-title":"Best Pract Res Clin Haematol"},{"issue":"101615492","key":"10.1016\/j.semarthrit.2026.153053_bib0145","article-title":"Safety of the COVID-19 vaccination in children with juvenile idiopathic arthritis-A observational study from two pediatric rheumatology centres in Poland","volume":"11","author":"Opoka-Winiarska","year":"2023","journal-title":"Front Pediatr"},{"issue":"6","key":"10.1016\/j.semarthrit.2026.153053_bib0146","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128979","article-title":"Fever as an initial manifestation of enthesitis-related arthritis subtype of juvenile idiopathic arthritis: retrospective study","volume":"10","author":"Guo","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.semarthrit.2026.153053_bib0147","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003296","article-title":"Diagnostic and prognostic role of synovial tissue analysis in juvenile idiopathic arthritis: a monocentric study","volume":"9","author":"Costi","year":"2023","journal-title":"RMD Open"},{"issue":"12","key":"10.1016\/j.semarthrit.2026.153053_bib0148","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1002\/acr.22903","article-title":"Cost-effectiveness analysis of first-line treatment with biologic agents in polyarticular juvenile idiopathic arthritis","volume":"68","author":"Luca","year":"2016","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2026.153053_bib0149","series-title":"The OMERACT handbook version 2.3","author":"Beaton","year":"2025"},{"issue":"7","key":"10.1016\/j.semarthrit.2026.153053_bib0150","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/1529-0131(199707)40:7<1202::AID-ART3>3.0.CO;2-R","article-title":"Preliminary definition of improvement in juvenile arthritis","volume":"40","author":"Giannini","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.semarthrit.2026.153053_bib0151","first-page":"1058","article-title":"Preliminary definition of disease flare in juvenile rheumatoid arthritis","volume":"29","author":"Brunner","year":"2002","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2026.153053_bib0152","first-page":"1058","article-title":"Preliminary definition of disease flare in juvenile rheumatoid arthritis","volume":"29","author":"Brunner","year":"2002","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2026.153053_bib0153","first-page":"789","article-title":"Preliminary validation of clinical remission criteria using the OMERACT filter for select categories of juvenile idiopathic arthritis","volume":"33","author":"Wallace","year":"2006","journal-title":"J Rheumatol"},{"issue":"11","key":"10.1016\/j.semarthrit.2026.153053_bib0154","first-page":"2290","article-title":"Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis","volume":"31","author":"Wallace","year":"2004","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2026.153053_bib0155","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1136\/annrheumdis-2015-208462","article-title":"Juvenile arthritis disease activity score is a better reflector of active disease than the disease activity score 28 in adults with polyarticular juvenile idiopathic arthritis","volume":"75","author":"Wu","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.semarthrit.2026.153053_bib0156","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1002\/art.1780241012","article-title":"Preliminary criteria for clinical remission in rheumatoid arthritis","volume":"24","author":"Pinals","year":"1981","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.153053_bib0157","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s10067-020-05404-w","article-title":"Disease course and obstetric outcomes of pregnancies in juvenile idiopathic arthritis: are there any differences among disease subtypes? A single-centre retrospective study of prospectively followed pregnancies in a dedicated pregnancy clinic","volume":"40","author":"Garcia-Fernandez","year":"2021","journal-title":"Clin Rheumatol"},{"issue":"11","key":"10.1016\/j.semarthrit.2026.153053_bib0158","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.3899\/jrheum.131536","article-title":"What matters most for patients, parents, and clinicians in the course of juvenile idiopathic arthritis? A qualitative study","volume":"41","author":"Guzman","year":"2014","journal-title":"J Rheumatol"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017226001435?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017226001435?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T04:02:28Z","timestamp":1788753748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017226001435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":158,"alternative-id":["S0049017226001435"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2026.153053","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Research definitions of flare in non-systemic juvenile idiopathic arthritis: An OMERACT scoping review","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2026.153053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"153053"}}